Nicorandil a magic bullet or a double edged sword in critically ill COVID-19 patients?

Mir, Tajamul H; Zargar, Parvaiz A; Jabeen, Bushra; Zahoor, Aariba

Mir, Tajamul H; Zargar, Parvaiz A; Jabeen, Bushra; Zahoor, Aariba.

Mir TH; Department of Nephrology, Khyber Medical Institute, Srinagar, India.
Zargar PA; Department of Cardiology, SMHS Hospital, Srinagar, India.
Jabeen B; Department of Pediatrics, GB Pant Pediatric Hospital, Srinagar, India.
Zahoor A; Department of Nephrology (Research wing), Khyber Medical Institute, Srinagar, India.

Clin Exp Pharmacol Physiol ; 48(6): 938-939, 2021 06.

Article in English | MEDLINE | ID: covidwho-1121626

Subject(s)

COVID-19; Nicorandil; Critical Illness; Humans; Nicorandil/adverse effects; SARS-CoV-2; Vasodilator Agents

Keywords

COVID-19 pandemic; nicorandil; pleotropic action; potassium ATP channels; potassium channel syndrome

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Nicorandil / COVID-19 Limits: Humans Language: English Journal: Clin Exp Pharmacol Physiol Year: 2021 Document Type: Article Affiliation country: 1440-1681.13487

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google